Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.19 - $1.94 $2,441 - $3,980
2,052 Added 61.51%
5,388 $7,000
Q2 2023

Aug 14, 2023

BUY
$0.92 - $2.03 $1,874 - $4,137
2,038 Added 157.01%
3,336 $5,000
Q1 2023

May 09, 2023

SELL
$1.45 - $3.49 $11,202 - $26,963
-7,726 Reduced 85.62%
1,298 $2,000
Q4 2022

Feb 10, 2023

BUY
$2.5 - $4.44 $13,530 - $24,029
5,412 Added 149.83%
9,024 $27,000
Q3 2022

Nov 10, 2022

BUY
$2.27 - $4.86 $8,199 - $17,554
3,612 New
3,612 $16,000
Q2 2022

Aug 15, 2022

SELL
$3.36 - $4.32 $4,327 - $5,564
-1,288 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$2.03 - $4.73 $2,632 - $6,134
-1,297 Reduced 50.17%
1,288 $5,000
Q4 2021

Feb 14, 2022

BUY
$4.45 - $9.4 $5,678 - $11,994
1,276 Added 97.48%
2,585 $12,000
Q3 2021

Nov 15, 2021

BUY
$6.6 - $12.75 $8,639 - $16,689
1,309 New
1,309 $9,000

About Miromatrix Medical Inc.


  • Ticker MIRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,899,200
  • Description
  • Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified huma...
More about MIRO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.